Disease Atlas / Disease detail

Behçet disease

An organ-specific atlas of relapsing mucocutaneous inflammation and ocular, vascular, neurologic, and gastrointestinal involvement.

Behcet disease · Behçet disease · Behçet syndrome

MONDO:0007191Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · f766efed55fb

Disease class: Behçet disease is a chronic relapsing inflammatory disorder that can affect blood vessels and multiple organs.
Core mechanism: The cause is not fully understood; genetic susceptibility and environmental factors contribute.
Genes or cause: Recurrent oral and genital ulcers and skin lesions are common features.
Typical features: Eye inflammation can cause pain, visual change, and vision loss and needs prompt assessment.
Variability: Joint, venous or arterial, neurologic, and gastrointestinal involvement have distinct risks and complications.
Diagnosis: No single test confirms Behçet disease; diagnosis uses the recurring clinical pattern and exclusion of alternatives.
Management: Tests help assess inflammation and organ involvement but do not independently confirm the disorder.
Treatment and research: Treatment is individualized by organ involvement, current activity, relapse risk, and prognostic factors.
Reading evidence: Colchicine is considered first for mucocutaneous and joint disease, with other immunomodulators for refractory disease.
Key caution: Organ- or life-threatening disease uses glucocorticoids with immunosuppressive therapy, with early biologic treatment considered.

A structured guide for understanding the disease and preparing for clinical conversations.

Behçet disease is a chronic relapsing inflammatory disorder that can affect blood vessels and multiple organs.

Eye inflammation can cause pain, visual change, and vision loss and needs prompt assessment.

The cause is not fully understood; genetic susceptibility and environmental factors contribute.

Recurrent oral and genital ulcers and skin lesions are common features.

Joint, venous or arterial, neurologic, and gastrointestinal involvement have distinct risks and complications.

No single test confirms Behçet disease; diagnosis uses the recurring clinical pattern and exclusion of alternatives.

Tests help assess inflammation and organ involvement but do not independently confirm the disorder.

Treatment is individualized by organ involvement, current activity, relapse risk, and prognostic factors.

Multidisciplinary follow-up across ophthalmology, rheumatology, neurology, vascular, and gastrointestinal care is important.

Clinical discussion should cover relapse pattern, organ involvement, urgent warning signs, treatment goals, and infection and medication risks.

This material is for disease education and is not a personal diagnosis or treatment instruction.

A trial registry status does not establish efficacy or regulatory approval.